cetylpyridinium chloride anhydrous and Epithelial Ovarian Cancer

cetylpyridinium chloride anhydrous has been researched along with Epithelial Ovarian Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alexandre, J; Arenzana-Seisdedos, F; Balabanian, K; Bouchet-Delbos, L; Broët, P; Camilleri-Broët, S; Emilie, D; Gaudin, F; Gladieff, L; Machelon, V; Nasreddine, S; Prévot, S; Pujade-Lauraine, E	1

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and Epithelial Ovarian Cancer

Article	Year
CXCL12 expression by healthy and malignant ovarian epithelial cells. BMC cancer, 2011, Mar-16, Volume: 11 Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Chemokine CXCL12; Clinical Trials, Phase III as Topic; Cohort Studies; Epithelial Cells; Female; Health; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Ovary; Predictive Value of Tests; Randomized Controlled Trials as Topic	2011

Article

Year

CXCL12 expression by healthy and malignant ovarian epithelial cells.

BMC cancer, 2011, Mar-16, Volume: 11

Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Ovarian Epithelial; Chemokine CXCL12; Clinical Trials, Phase III as Topic; Cohort Studies; Epithelial Cells; Female; Health; Humans; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Ovary; Predictive Value of Tests; Randomized Controlled Trials as Topic

2011